Global growth equity investor Verlinvest has partnered with Sinomedica, a Swiss group of acupuncture centres. Verlinvest is a global growth equity investor that backs category-defining consumer brands.
From the other side, Sinomedica is pioneering a science-based approach to medical acupuncture that enables a range of treatments and applications, including to tackle obesity. This investment from Verlinvest will help Sinomedica to accelerate growth in its existing home market of Switzerland and into new European markets, as it capitalises on increasing interest in the acupuncture field.
MLL Legal has acted as lead counsel to Verlinvest in its investment. The team was co-led by Cristoph Heiz (of counsel, corporate & m&a, pictured left) and Sergio Bortolani (partner, corporate & m&a, pictured right) and included Thomas Nabholz (partner, tax), Marc Baumberger (associate, corporate & m&a) and Thais Obrist-Bdine (associate, tax).